![Thomas Civik](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Thomas Civik
Vorstandsvorsitzender bei
PYXIS ONCOLOGY, INC.
Vermögen: 667 877 $ am 30.06.2026
Profil
Thomas Civik is Chief Executive Officer & Director at Pyxis Oncology, Inc. since 2026 and Independent Chairman at Imcheck Therapeutics SAS since 2023.
Former roles include President, Chief Executive Officer & Director at Five Prime Therapeutics, Inc. from 2020 to 2021; Independent Chairman at Repare Therapeutics, Inc. from 2021 to 2026; Vice President-Avastin Sales & Marketing at Genentech, Inc. from 2000 to 2017; and Chief Commercial Officer at Foundation Medicine, Inc. from 2017 to 2019.
Education includes undergraduate studies at St. Norbert College, Inc. and an MBA from Kellogg School of Management.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
PYXIS ONCOLOGY, INC. 0,35 % | 20.04.2026 | 221.886 ( 0,35 % ) | 667 877 $ | 30.06.2026 |
Aktive Positionen von Thomas Civik
| Unternehmen | Position | Beginn |
|---|---|---|
| PYXIS ONCOLOGY, INC. | Vorstandsvorsitzender | 03.02.2026 |
Imcheck Therapeutics SAS
 Imcheck Therapeutics SAS Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops immunotherapeutic anti-cancer strategies for research | Vorsitzender | 23.03.2023 |
Ehemalige bekannte Positionen von Thomas Civik
| Unternehmen | Position | Ende |
|---|---|---|
| REPARE THERAPEUTICS INC. | Vorsitzender | 28.01.2026 |
| FIVE PRIME THERAPEUTICS, INC. | Vorstandsvorsitzender | 16.04.2021 |
| FOUNDATION MEDICINE INC | Corporate Officer/Principal | 01.09.2019 |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Vertrieb & Marketing | 01.11.2017 |
Ausbildung von Thomas Civik
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
88
Beziehungen ersten Grades
8
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 8 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Health Technology |
Five Prime Therapeutics, Inc.
 Five Prime Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops protein therapeutics for cancer and inflammatory diseases | Health Technology |
St. Norbert College, Inc.
 St. Norbert College, Inc. Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Foundation Medicine, Inc.
 Foundation Medicine, Inc. Medical/Nursing ServicesHealth Services Provides diagnostic solutions for cancer care | Health Services |
Kellogg School of Management
 Kellogg School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Imcheck Therapeutics SAS
Imcheck Therapeutics SAS Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops immunotherapeutic anti-cancer strategies for research | Health Technology |
Repare Therapeutics, Inc.
 Repare Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery and development of novel cancer therapies | Health Technology |
Pyxis Oncology, Inc.
 Pyxis Oncology, Inc. Pharmaceuticals: MajorHealth Technology Operates as a preclinical oncology company focused on developing an arsenal of next-generation therapeutics | Health Technology |
Wählen Sie MarketScreener 
